Basic Stats
| LEI | 5493001Z2JZQT4C63C50 |
| CIK | 1818093 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to The Beauty Health Company
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| September 4, 2025 |
Exhibit 4.1 SUPPLEMENTAL INDENTURE NO. 1 SUPPLEMENTAL INDENTURE NO. 1 (this “Supplemental Indenture”), dated as of September 4, 2025, by and among The Beauty Health Company, a Delaware corporation (the “Company”), the existing guarantors party hereto (the “Existing Guarantors”), the entities listed on Schedule I hereto (each a “Guaranteeing Subsidiary”) and U.S. Bank Trust Company, National Associ |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health Comp |
|
| August 7, 2025 |
Exhibit 99.1 BeautyHealth Reports Second Quarter 2025 Financial Results Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9™ Booster Long Beach, Calif., August 7, 2025 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| August 7, 2025 |
EXECUTION VERSION THE BEAUTY HEALTH COMPANY and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee and Collateral Agent INDENTURE Dated as of May 27, 2025 7.95% Convertible Senior Secured Notes due 2028 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 27 Section 1.03. Interpretation 27 Section 1.04. Accounting |
|
| August 1, 2025 |
STATE OF DELAWARE CERTIFICATE OF CORRECTION TO SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE BEAUTY HEALTH COMPANY The Beauty Health Company, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”). |
|
| August 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| June 17, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| May 27, 2025 |
Exhibit 4.1 THE BEAUTY HEALTH COMPANY and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee and Collateral Agent INDENTURE Dated as of May 27, 2025 7.95% Convertible Senior Secured Notes due 2028 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction 1 Section 1.01. Definitions 1 Section 1.02. Other Definitions 22 Section 1.03. Interpretation 23 Section 1.04. Accounting Terms |
|
| May 21, 2025 |
Exhibit 10.1 The Beauty Health Company [FORM OF] Exchange Agreement May 21, 2025 Table of Contents Page Section 1. Definitions 1 Section 2. Rules of Construction 4 Section 3. The Exchange 5 (a) Generally 5 (b) The Closing 5 Section 4. Representations, Warranties and Covenants of the Company and the Guarantors 7 (a) Due Formation, Valid Existence and Good Standing; Power to Perform Obligations 7 (b |
|
| May 21, 2025 |
Exhibit 99.1 The BeautyHealth Company Announces Convertible Debt Refinancing Refinancing extends maturity of existing debt and strengthens Company’s financial position to advance growth strategy LONG BEACH, Calif.-(GLOBE NEWSWIRE)—May 21, 2025 – The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced that it entered into privately negotiated exchange agreement |
|
| May 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| May 8, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission F |
|
| May 8, 2025 |
BeautyHealth Reports First Quarter 2025 Financial Results Exhibit 99.1 BeautyHealth Reports First Quarter 2025 Financial Results Long Beach, Calif., May 8, 2025 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 (“Q1 2025”). “Our first quarter results reflect strong execution and continued momentum in our transformat |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health Com |
|
| April 25, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| March 12, 2025 |
Exhibit 99.1 BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results Delivers fourth quarter and full year net sales of $83.5 million and $334.3 million Long Beach, Calif., March 12, 2025 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 (“Q4 2024”). “In |
|
| March 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39565 The Beauty Health Company (Exact name of registrant as speci |
|
| March 12, 2025 |
Subsidiaries of The Beauty Health Company EXHIBIT 21.1 SUBSIDIARIES OF THE BEAUTY HEALTH COMPANY Name of Subsidiary State or Jurisdiction of Incorporation LCP Edge Intermediate, LLC Delaware Edge Systems Holdings Corporation Delaware Edge Systems Intermediate, LLC Delaware Esthetic Medical Inc. California HydraFacial LLC California The HydraFacial Company Mexico Holdings, LLC Delaware The HydraFacial Company MX, S. de R.L. de C.V. Mexico |
|
| March 12, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| March 12, 2025 |
Effective May 4, 2021 THE BEAUTY HEALTH COMPANY INSIDER TRADING POLICY PURPOSE This Insider Trading Policy (the “Policy”) provides guidelines with respect to transactions in the securities of The Beauty Health Company (the “Company”) and the handling of confidential information about the Company and its subsidiaries and the companies with which the Company and its subsidiaries do business. |
|
| March 12, 2025 |
DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following summary of the material terms of the securities of The Beauty Health Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). |
|
| February 28, 2025 |
Offer Letter with Sheri Lewis, dated March 25, 2024 CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED March 25, 2024 Sheri Lewis [*****] Dear Sheri, We are excited to extend you an offer to join Hydrafacial LLC, a BeautyHealth Company, as our Chief Supply Chain and Operations Officer. |
|
| February 28, 2025 |
The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments LONG BEACH, Calif. |
|
| February 28, 2025 |
Offer Letter with Ronald Menezes, dated October 9, 2024 CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED October 9, 2024 Ron Menezes [*****] Dear Ron, We are excited to extend you an offer to join Hydrafacial LLC, a BeautyHealth Company, as our Chief Revenue Officer. |
|
| February 28, 2025 |
BEAUTYHEALTH NAMES SHERI LEWIS AS CHIEF SUPPLY CHAIN AND OPERATIONS OFFICER BEAUTYHEALTH NAMES SHERI LEWIS AS CHIEF SUPPLY CHAIN AND OPERATIONS OFFICER LONG BEACH, Calif. |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2025 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| December 17, 2024 |
EX-99.1 2 exhibit991-beautyhealthsfb.htm EX-99.1 BeautyHealth Appoints Stephen J. Fanning to Board of Directors Medical Aesthetics Veteran Brings Extensive Industry Knowledge and Proven Success in Driving Global Growth LONG BEACH, Calif.-(BUSINESS WIRE)—December 17, 2024 - The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the appointment of medical aesthe |
|
| December 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| November 14, 2024 |
SKIN / The Beauty Health Company / Divisadero Street Capital Management, LP Passive Investment SC 13G/A 1 d1152808913g-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* The Beauty Health Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 88331L108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Ch |
|
| November 14, 2024 |
SKIN / The Beauty Health Company / Luxor Capital Partners, Lp Passive Investment SC 13G/A 1 beauty13ga3-11142024.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 3)* The Beauty Health Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 88 |
|
| November 12, 2024 |
CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED SEPARATION AND TRANSITION AGREEMENT This Separation and Transition Agreement (“Agreement”) is made and entered into as of November 11, 2024 (the “Signing Date”), but for all purposes shall be effective as of October 14, 2024 (the “Effective Date”), by and between Daniel Watson, an individual (“Employee”), and Hydrafacial LLC, a California corporation (the "Company") (together, the "Parties"), is a severance agreement which includes a general release of claims. |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of inco |
|
| November 12, 2024 |
Exhibit 99.1 BeautyHealth Reports Third Quarter 2024 Financial Results Delivers third quarter net sales of $78.8 million; Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA Booster Long Beach, Calif., November 12, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financia |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health |
|
| October 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissi |
|
| August 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissi |
|
| August 8, 2024 |
Exhibit 99.1 BeautyHealth Reports Second Quarter 2024 Financial Results Delivers second quarter net sales of $90.6 million; Year-over-year operating expense improvement of nearly $18 million or 22%; Revises full year financial guidance Long Beach, Calif., August 8, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financial result |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| August 8, 2024 |
Bonus Opportunity Letter, dated August 6, 2024, for Michael Monahan USACTIVE-181295609.1 August 6, 2024 Mike Monahan 3600 E. Burnett St. Long Beach, CA 90815 Re: Cash-Based Performance Bonus Opportunity Dear Mike: The Beauty Health Company and HydraFacial LLC (together with any of their respective successors or assigns, the “Company”), wish to provide you with the following cash-based performance award opportunity under the terms and on the conditions outlined bel |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health Comp |
|
| June 11, 2024 |
SECOND CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE BEAUTY HEALTH COMPANY (Pursuant to Section 242 of the General Corporation Law of the State of Delaware) The Beauty Health Company (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (as amended from time to time, the “DGCL”), does hereby certify as follows: 1. |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| June 11, 2024 |
CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE BEAUTY HEALTH COMPANY (Pursuant to Section 242 of the General Corporation Law of the State of Delaware) The Beauty Health Company (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (as amended from time to time, the “DGCL”), does hereby certify as follows: 1. |
|
| May 17, 2024 |
SKIN / The Beauty Health Company / Divisadero Street Capital Management, LP Passive Investment SC 13G 1 d1105249613-g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* The Beauty Health Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 88331L108 (CUSIP Number) May 10, 2024 (Date of Event Which Requires Filing of this Statement) Check the app |
|
| May 9, 2024 |
ween The Beauty Health Company and Goldman Sachs & Co. LLC \\\DC - 71532/300 - #1291878 v5 PURCHASE AGREEMENT Purchase Agreement, dated December 15, 2023 (the “Purchase Agreement”), between The Beauty Health Company (the “Purchaser”) and Goldman Sachs & Co. |
|
| May 9, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission F |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health Com |
|
| May 9, 2024 |
Exhibit 99.1 BeautyHealth Reports First Quarter 2024 Financial Results Delivers first quarter net sales of $81.4 million; year-over-year operating expense improvement of $6.1 million Repurchases $192.3 million of convertible notes through May 8th Long Beach, Calif., May 9, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financia |
|
| May 9, 2024 |
, by and between The Beauty Health Company and Goldman Sachs & Co. LLC \\\DC - 71532/300 - #1291878 v5 PURCHASE AGREEMENT Purchase Agreement, dated April 1, 2024 (the “Purchase Agreement”), between The Beauty Health Company (the “Purchaser”) and Goldman Sachs & Co. |
|
| May 2, 2024 |
CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED SEPARATION, TRANSITION AND GENERAL RELEASE AGREEMENT This Separation, Transition and General Release Agreement (“Agreement”) made this 26th day of April 2024 (the “Effective Date”), by and between Brad Hauser, an individual (“Employee”), and Hydrafacial LLC, a California limited liability company (the "Company") (together, the "Parties"), is a separation agreement which includes a general release of claims. |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorp |
|
| April 26, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 10, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 8, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| April 8, 2024 |
The Beauty Health Company Amended and Restated Executive Severance Plan US-DOCS\148350726.5 THE BEAUTY HEALTH COMPANY AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN The Beauty Health Company (the “Company”), has adopted this The Beauty Health Company Amended and Restated Executive Severance Plan, including the attached Exhibits (the “Plan”), effective as of April 5, 2024 (the “Effective Date”), for the benefit of Participants (as defined below) on the terms and conditi |
|
| April 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| April 8, 2024 |
Marla Beck CEO Employment Agreement 1 ACTIVE/128259303.13 CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of April 8, 2024, and effective as of April 8, 2024 (the “Effect |
|
| March 14, 2024 |
SKIN / The Beauty Health Company / LCP Edge Holdco LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 4)* The Beauty Health Company (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 88331L 108 (CUSIP Number) LCP Edge H |
|
| March 12, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39565 The Beauty Health Company (Exact name of registrant as speci |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| March 12, 2024 |
BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer LONG BEACH, Calif. |
|
| March 12, 2024 |
he Beauty Health Company Amended and Restated Clawback Policy 1 US-DOCS\143410591.3 THE BEAUTY HEALTH COMPANY AMENDED AND RESTATED CLAWBACK POLICY The Beauty Health Company (the “Company”) has adopted this Amended and Restated Clawback Policy (this “Policy”), effective as of October 2, 2023 (the “Effective Date”). This Policy amends, restates and supersedes in its entirety the Company’s Clawback Policy, which was originally adopted by the Company on May 4, 2 |
|
| March 12, 2024 |
Exhibit 99.1 BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to flagship brand Hydrafacial, today announced financial results for the |
|
| March 12, 2024 |
Subsidiaries of The Beauty Health Company EXHIBIT 21.1 SUBSIDIARIES OF THE BEAUTY HEALTH COMPANY Name of Subsidiary State or Jurisdiction of Incorporation LCP Edge Intermediate, LLC Delaware Edge Systems Holdings Corporation Delaware Edge Systems Intermediate, LLC Delaware Esthetic Medical Inc. Arizona HydraFacial LLC California The HydraFacial Company Mexico Holdings, LLC Delaware The HydraFacial Company MX, S. de R.L. de C.V. Mexico The |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| February 14, 2024 |
SKIN / The Beauty Health Company / Luxor Capital Group, LP Passive Investment SC 13G/A 1 beauty13ga2-02142024.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 2)* The Beauty Health Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 88 |
|
| February 13, 2024 |
SKIN / The Beauty Health Company / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0416-beautyhealthcompanycl.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Beauty Health Company Class A Title of Class of Securities: Common Stock CUSIP Number: 88331L108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate |
|
| February 9, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* The Beauty Health Company (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 88331L108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of in |
|
| December 14, 2023 |
, dated December 8, 2023, by and between The Beauty Health Company and CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED December 8, 2023 Andrew Stanleick Via email Re: Separation of Employment Dear Andrew: As a follow up to our conversations, this letter confirms the terms related to the Company’s exercise of its option to terminate your employment without cause. |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| December 1, 2023 |
Form of Restricted Stock Unit Agreement THE BEAUTY HEALTH COMPANY 2021 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT GRANT NOTICE The Beauty Health Company, a Delaware corporation (the “Company”), has granted to the participant listed below (“Participant”) the Restricted Stock Units (the “RSUs”) described in this Restricted Stock Unit Grant Notice (this “Grant Notice”), subject to the terms and conditions of The Beauty Health Company 2021 Incentive Award Plan (as amended from time to time, the “Plan”) and the Restricted Stock Unit Agreement attached hereto as Exhibit A (the “Agreement”), both of which are incorporated into this Grant Notice by reference. |
|
| November 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health |
|
| November 13, 2023 |
Exhibit 99.1 BeautyHealth Reports Third Quarter 2023 Financial Results Revises financial guidance on lower-than-expected U.S. revenue and incurs restructuring charges for device upgrades Delivers net sales of $97.4 million driven by double digit growth in APAC and EMEA Long Beach, Calif., November 13, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announ |
|
| November 13, 2023 |
, dated November 13, 2023, by and between The Beauty Health Company and USACTIVE-175944529.6 November 12, 2023 Via Email Marla Beck Re: Offer Letter As Interim CEO of The Beauty Health Company Dear Ms. Beck: We are pleased to extend you an offer of employment with The Beauty Health Company (the “Company”) as its interim Chief Executive Officer under the terms provided in this offer letter. The term of your employment as interim CEO shall be six (6) months (the “Term”) |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 13, 2023 |
1 BeautyHealth Announces Leadership Transition Beauty Industry Veteran and BeautyHealth Director Marla Beck to Serve as Interim CEO, Succeeding Andrew Stanleick Long Beach, Calif. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| September 13, 2023 |
BeautyHealth Announces Business Transformation Program to Drive Profitability and Growth; Board of Directors Authorizes $100 Million Share Repurchase Sep 12, 2023 First phase of the transformation program expected to generate over $20 million annualized cost savings during Q1 2024; second phase expected to generate over $15 million annualized cost savings during Q2 2024 Company re-affirms long-term 2025 financial guidance of $600 to $700 million net sales, up to 500 basis points gross margin expansion vs. |
|
| September 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commi |
|
| August 9, 2023 |
, dated August 10, 2023, by and between The Beauty Health Company and Liyuan Woo CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED August 3, 2023 Liyuan Woo Via email Re: Separation of Employment Dear Liyuan: As a follow up to our conversations, this letter confirms the terms related to the Company’s exercise of its option to terminate your employment without cause. |
|
| August 9, 2023 |
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of August 7, 2023 and effective as of August 10, 2023 (the “Effective Date”) between The Beauty Health Company (“Parent”), Hydrafacial LLC (the “OpCo” and, together with Parent, the “Company”), and Michael Monahan (“Executive”). |
|
| August 9, 2023 |
Exhibit 99.1 BeautyHealth Reports Second Quarter 2023 Financial Results Delivers double-digit net sales growth on demand for Hydrafacial Confirms 2023 net sales and 2025 financial guidance, refines 2023 adjusted EBITDA margin guidance Long Beach, Calif., August 9, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the second q |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| August 9, 2023 |
BeautyHealth Names Michael Monahan Chief Financial Officer BeautyHealth Names Michael Monahan Chief Financial Officer LONG BEACH, Calif. – August 9, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announces Michael Monahan has been named Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the t |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health Comp |
|
| July 7, 2023 |
SKIN / Beauty Health Company (The) - Class A / LCP Edge Holdco LLC - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 3)* The Beauty Health Company (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 88331L 108 (CUSIP Number) LCP Edge H |
|
| June 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| June 2, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* The Beauty Health Company (Name of Issuer) Class A common stock, par value $0.0001 per share (Title of Class of Securities) 88331L108 (CUSIP Number) May 26, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| June 2, 2023 |
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| May 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The Beauty Health Com |
|
| May 10, 2023 |
a20231qearningsdeckvf Hydrafacial is upping its cool factor, one brand partnership at a time The Hydrafacial Phenomenon: Why Everyone Is Obsessed With This In-Office Treatment“ ” “ ” |
|
| May 10, 2023 |
Exhibit 99.1 BeautyHealth Reports First Quarter 2023 Financial Results On strong consumer demand, delivers double-digit net sales growth in line with 2023 plan Raises fiscal 2023 net sales guidance Long Beach, Calif., May 10, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2023. For the qua |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| April 19, 2023 |
Exhibit 99.1 Maturing into a Multi-Brand Ecosystem, BeautyHealth Appoints Aesthetics Veteran Brad Hauser as Chief Operating Officer Newly created role establishes end-to-end product oversight, from innovation to go-to-market LONG BEACH, Calif.— April 19, 2023 —The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced Brad Hauser’s promotion to Chief Operating Of |
|
| April 19, 2023 |
Promotion Offer Letter with Brad Hauser, dated April 7, 2023 Exhibit 10.1 April 7, 2023 Dear Brad, Congratulations on your promotion to your new role as Chief Operating Officer! In this role you will continue to report directly to me and will remain a member of the executive committee. Based on your promotion, the Board of Directors has approved your new annual salary of $475,000. This amount, less applicable withholdings and deductions will be effective Ap |
|
| April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2023 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| April 14, 2023 |
First Amendment to The Beauty Health Company Executive Severance Plan Exhibit 10.1 FIRST AMENDMENT TO THE BEAUTY HEALTH COMPANY EXECUTIVE SEVERANCE PLAN This First Amendment (this “First Amendment”) to The Beauty Health Company Executive Severance Plan (the “Plan”) is made and adopted by the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of The Beauty Health Company, a Delaware corporation (the “Company”), effective as of February 5 |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2023 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| March 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| March 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39565 The Beauty Health Company (Exact name of registrant as speci |
|
| March 1, 2023 |
EXHIBIT 21.1 SUBSIDIARIES OF THE BEAUTY HEALTH COMPANY Name of Subsidiary State or Jurisdiction of Incorporation LCP Edge Intermediate, LLC Delaware Edge Systems Holdings Corporation Delaware Edge Systems Intermediate, LLC Delaware HydraFacial LLC California The Personalized Beauty Company, Inc. Delaware The HydraFacial Company MX, S. de R.L. de C.V. Mexico The HydraFacial Company Mexico Holdings, |
|
| March 1, 2023 |
Exhibit 4.4 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following summary of the material terms of the securities of The Beauty Health Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This description of the terms of our stock does not purport to be a complete s |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| February 28, 2023 |
Exhibit 99.1 BeautyHealth to Acquire SkinStylus®, FDA-Cleared Microneedling Device Acquisition is a strategic step in portfolio build-up and BeautyHealth long-term vision Long Beach, Calif., February 28, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand HydrafacialTM, today announced a definitive agreement to acquire SkinStylus®, an FDA-cleared microneedling device. The agree |
|
| February 28, 2023 |
BeautyHealth Reports Full Year and Fourth Quarter 2022 Financial Results Exhibit 99.1 BeautyHealth Reports Full Year and Fourth Quarter 2022 Financial Results •Delivers +41% year-over-year topline growth for the year and exceeds market expectations for eighth consecutive quarter •Increases adjusted EBITDA +46% year-over-year, landing within guided annual range •Sets 2023 profitable growth targets on strategy to increase operating leverage and accelerate in China, confi |
|
| February 28, 2023 |
a20224qearningspresentat Jan-19 Jul-19 Jan-20 Jun-20 Dec-20 Jun-21 Dec-21 Jun-22 Dec-22 Interest over time 2021 average I discovered the Hydrafacial when I was working in France. I really saw the difference. My skin has never felt so clean and glowing. • • |
|
| February 28, 2023 |
CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED STOCK PURCHASE AGREEMENT among DR. |
|
| February 14, 2023 |
SKIN / The Beauty Health Company Class A / Luxor Capital Group, LP Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1)* The Beauty Health Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 88331L108 (CUSIP Number) December 31, |
|
| February 9, 2023 |
SKIN / The Beauty Health Company Class A / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0390-beautyhealthco.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Beauty Health Co. Title of Class of Securities: Common Stock CUSIP Number: 88331L108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate th |
|
| January 13, 2023 |
Filed pursuant to Rule 424(b)(3) Registration No. 333-257995 Registration No. 333-267051 THE BEAUTY HEALTH COMPANY 68,433,360 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus relates to the resale from time to time of (i) an aggregate of 68,433,360 shares of Class A common stock |
|
| January 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2023 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissi |
|
| December 30, 2022 |
As filed with the Securities and Exchange Commission on December 30, 2022 As filed with the Securities and Exchange Commission on December 30, 2022 Registration No. |
|
| December 30, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Post-Effective Amendment No. 3 to Form S-1 on Form S-3 (Form Type) The Beauty Health Company (Exact Name of Registrant as Specified in its Charter) Table3: Combined Prospectuses Security Type Security Class Title Amount of Securities Previously Registered(1) Maximum Aggregate Offering Price of Securities Previously Registered Form Type File Number Initi |
|
| December 15, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission Fi |
|
| December 15, 2022 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 16 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement |
|
| December 15, 2022 |
December 15, 2022 Via EDGAR Transmission Division of Corporation Finance Office of Industrial Applications and Services U. |
|
| December 15, 2022 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 13 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement |
|
| December 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04321 The Beauty Health Company (Exact name of |
|
| December 15, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Nu |
|
| December 15, 2022 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 15 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement |
|
| December 15, 2022 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 14 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement |
|
| December 15, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File N |
|
| November 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| November 15, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 12 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information co |
|
| November 15, 2022 |
Exhibit 10.1 EXECUTION VERSION AMENDED AND RESTATED CREDIT AGREEMENT dated as of November 14, 2022 among THE BEAUTY HEALTH COMPANY (as successor by assumption to HydraFacial LLC), as Borrower The Other Loan Parties Party Hereto The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent, JPMORGAN CHASE BANK, N.A., as Sole Bookrunner and Sole Lead Arranger TABLE OF CONTENTS Page |
|
| November 10, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 11 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information co |
|
| November 10, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commiss |
|
| November 10, 2022 |
BeautyHealth Enters into $100 Million Accelerated Share Repurchase Agreement Exhibit 99.1 BeautyHealth Enters into $100 Million Accelerated Share Repurchase Agreement Long Beach, Calif., November 10, 2022 ? The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that it has entered into an accelerated share repurchase agreement (?ASR?) with JP Morgan Chase Bank, N.A., to repurchase an additional $100 million of the Company?s common sto |
|
| November 9, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 |
|
| November 9, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 10 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information co |
|
| November 9, 2022 |
Separation Agreement, dated as of August 3, 2022, between Hydrafacial LLC and Indra Pamamull Exhibit 10.2 CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED SEPARATION AGREEMENT This agreement (?Separation Agreement?) is entered into as of 3 August 2022 but shall be effective as of 8 June 2022 between: (1)HydraFacial LLC (f/k/a Edge Systems, LL |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commiss |
|
| November 8, 2022 |
? ? ? ? ? ? ? ? ? Reconciliation of net income to adjusted EBITDA ($mm) Net sales Net income (loss) Adjusted to exclude the following: Change in FV of warrant liability Change in FV of earn-out shares liability Amortization expense Gain / loss on disposal of assets Stock-based compensation expense Other expense (income) Management fees1 Transaction related costs2 Other non-recurring and one-time fees3 Aaaregate adjustment for income taxes Adiusted net income (loss) Depreciation expense Interest expense Foreign currency (gain) loss, net Remaininq benefit for income taxes Adjusted EBITDA Adjusted EBITDA margin Three months ended September 30, 2022 2021 $88:8 $68. |
|
| November 8, 2022 |
Exhibit 99.1 BeautyHealth Reports Third Quarter 2022 Financial Results Net sales beat expectations for seventh consecutive quarter Company raises 2022 net sales guidance on continued momentum and strong demand, revises adjusted EBITDA guidance against a complex macro backdrop Long Beach, Calif., November 8, 2022 ? The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today |
|
| September 27, 2022 |
Exhibit 10.1 JPMorgan Chase Bank, National Association New York Branch 383 Madison Avenue New York, NY, 10179 September 27, 2022 To: The Beauty Health Company 2165 Spring Street Long Beach, CA 90806 Attention: Liyuan Woo Telephone No.: Email: With a Copy to: Paul Bokota Telephone No.: Email: Re: Master Confirmation?Uncollared Accelerated Share Repurchase This master confirmation (this ?Master Conf |
|
| September 27, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 9 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| September 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commi |
|
| September 27, 2022 |
Exhibit 99.1 BeautyHealth Announces $200 million Share Repurchase Authorization Enters into $100 million accelerated share repurchase agreement Long Beach, Calif., Sep. 27, 2022 ? The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has authorized a share repurchase program of up to $200 million of the Company?s outstanding common sto |
|
| September 15, 2022 |
Analyst & Investor Day September 15, 2022 The road to BeautyHealth Brent Saunders Executive Chairman 2 What makes Hydrafacial attractive? Criteria Leading position in attractive and growing industry P Scientific / brand differentiation P Sustainable competitive advantages P Suitable platform to build a leading aesthetics technology company focused on allied healthcare professionals P Long-term gro |
|
| September 15, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commi |
|
| September 15, 2022 |
Exhibit 99.1 A Harbinger of Beauty Industry Resiliency, BeautyHealth Announces Three-Year Plan to Double Sales, At Least Triple Profit Company hosts Analyst and Investor Day in New York City today Expects growth across all channels and geographies, projecting EMEA and APAC businesses to overtake Americas by 2025 Long Beach, Calif., September 15, 2022 ? The Beauty Health Company (NASDAQ: SKIN), hom |
|
| September 2, 2022 |
Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-267051 PROSPECTUS FOR 65,618 SHARES OF CLASS A COMMON STOCK OF THE BEAUTY HEALTH COMPANY This prospectus relates to the resale or other disposition from time to time of up to an aggregate of 65,618 shares of Class A common stock, par value $0.0001 per share (the ?Class A Common Stock?), of The Beauty Health Company by the secu |
|
| August 31, 2022 |
The Beauty Health Company 2165 Spring Street Long Beach, CA 90806 The Beauty Health Company 2165 Spring Street Long Beach, CA 90806 August 31, 2022 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N. |
|
| August 26, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 8 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| August 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissi |
|
| August 24, 2022 |
As filed with the Securities and Exchange Commission on August 24, 2022 Table of Contents As filed with the Securities and Exchange Commission on August 24, 2022 Registration No. |
|
| August 24, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) The Beauty Health Company (Exact Name of Registrant as Specified in its Charter) Table1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, $0. |
|
| August 9, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 7 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| August 9, 2022 |
Retention Agreement, dated May 7, 2022, between Daniel Watson and The Beauty Health Company Exhibit 10.2 Date: May 5, 2022 Daniel Watson Re: Retention Bonus Dear Dan: As you know, The Beauty Health Company (the ?Company?) desires to have you remain with the Company in your current role. We consider your continued service and dedication to the Company to be critical to our business success. To incentivize you to remain employed with the Company, we are pleased to offer you a retention bon |
|
| August 9, 2022 |
Exhibit 99.1 BeautyHealth Reports Record Second Quarter 2022 Financial Results All-time high quarterly net sales of $103.5 million, up +55.7% YoY Company raises net sales guidance and reaffirms adjusted EBITDA outlook for the year Exceptional results driven by acceleration of HydraFacial delivery system placements globally, with segment revenue up +85.4% YoY; healthy consumer interest Long Beach, |
|
| August 9, 2022 |
Separation Agreement, dated as of August 3, 2022, between Hyrdrafacial LLC and Indra Pamamull Exhibit 10.3 CERTAIN INFORMATION, IDENTIFIED BY [*****], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL, AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED SEPARATION AGREEMENT This agreement (?Separation Agreement?) is entered into as of 3 August 2022 but shall be effective as of 8 June 2022 between: (1)HydraFacial LLC (f/k/a Edge Systems, LL |
|
| August 9, 2022 |
1 Q2 2022 EARNINGS PRESENTATION AUGUST 9, 2022 2 Opening Remarks AGENDA Q2 2022 Results & Outlook Q&A 3 DI SCLAI MER This Presentation contains certain forward-looking statements. |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| August 9, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The |
|
| August 8, 2022 |
SKIN / The Beauty Health Company Class A / Luxor Capital Group, LP Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. )* The Beauty Health Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 88331L108 (CUSIP Number) July 27, 2022 |
|
| August 3, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorp |
|
| August 3, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 6 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| June 29, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 4 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| June 29, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| June 29, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 5 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| June 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorpo |
|
| June 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| June 10, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 3 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| June 9, 2022 |
1 2 3 ? ? ? ? ? ? ? ? ? 4 5 6 7 8 9 ? ? ? ? ? ? ? ? 10 ? ? ? ? 11 12 ? ? ? ? ? 13 ? ? ? ? 14 15 16 ? ? ? 17 18 19 20 21 22 ? ? ? ? ? ? ? ? ? ? 23 24 25 26 27 28 |
|
| June 9, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| June 7, 2022 |
DEFA14A 1 proxyfiling2022supplement.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitt |
|
| June 6, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 2 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| June 6, 2022 |
BEAUTYHEALTH APPOINTS BLUEMERCURY FOUNDER MARLA BECK TO BOARD OF DIRECTORS Exhibit 99.1 BEAUTYHEALTH APPOINTS BLUEMERCURY FOUNDER MARLA BECK TO BOARD OF DIRECTORS LONG BEACH, Calif., June 6, 2022?The Beauty Health Company (NASDAQ:SKIN), the breakthrough category creator at the intersection of traditional beauty and aesthetics with its flagship HydraFacial brand, today announced the appointment of Marla Beck to its Board of Directors. The Bluemercury founder will join the |
|
| June 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| May 10, 2022 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 The |
|
| May 10, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 1 (to prospectus dated May 5, 2022) THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information con |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| May 10, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| May 10, 2022 |
FIRST QUARTER 2022 EARNINGS PRESENTATION May 10, 2022 2 DISCLAIMER This Presentation contains certain forward-looking statements. |
|
| May 10, 2022 |
Exhibit 99.1 The Beauty Health Company Reports Strong First Quarter 2022 Financial Results Increases 2022 Financial Guidance Long Beach, Calif., May 10, 2022 ? The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), the breakthrough category creator at the intersection of traditional beauty and aesthetics, today announced financial results for the first quarter ended March 31, 20 |
|
| May 9, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 76,040,010 SHARES OF CLASS A COMMON STOCK 6,970,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,970,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus relates to the resale from time to time of (i) an aggregate of 76,040,010 shares of Class A common stock, par value $0.0001 per shar |
|
| May 2, 2022 |
Table of Contents As filed with the Securities and Exchange Commission on April 29, 2022 Registration No. |
|
| March 10, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissio |
|
| March 10, 2022 |
• • • • • • • • • ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? |
|
| March 7, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commission |
|
| March 7, 2022 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 13 (to prospectus dated July 26, 2021) THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| March 7, 2022 |
Exhibit 99.1 The Beauty Health Company Introduces New Digitally Connected HydraFacial Syndeo? Delivery System Launch Represents a Significant Technology Upgrade from Existing HydraFacial Delivery System, with Data Collection Capabilities for a Personalized and Connected Experience Long Beach, Calif., ? March 7, 2022- The Beauty Health Company (?BeautyHealth? or the ?Company?; NASDAQ:SKIN), a globa |
|
| March 1, 2022 |
As filed with the Securities and Exchange Commission on March 1, 2022 As filed with the Securities and Exchange Commission on March 1, 2022 Registration No. |
|
| March 1, 2022 |
Exhibit 4.4 DESCRIPTION OF REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following summary of the material terms of the securities of The Beauty Health Company registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the ?Exchange Act?). This description of the terms of our stock does not purport to be a complete s |
|
| March 1, 2022 |
424B3 1 a424b3-fy2110xk.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 12 (to prospectus dated July 26, 2021) THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to upd |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04321 The Beauty Health Company (Exact name of r |
|
| March 1, 2022 |
EXHIBIT 10.9 Employment Contract Arbeitsvertrag between zwischen HydraFacial Germany GmbH Borsig Stra?e 18 65025 Wiesbaden Germany - Hereinafter referred to as "Company" - - im Folgenden ?die Gesellschaft? genannt ? and und Stephan Becker [REDACTED] - Hereinafter referred to as "Employee" ? - im Folgenden ?Arbeitnehmer? genannt - Sec. 1 Start of employment, Duration ? 1 Beginn des Arbeitsverh?ltni |
|
| March 1, 2022 |
EXHIBIT 21.1 SUBSIDIARIES OF THE BEAUTY HEALTH COMPANY Name of Subsidiary State or Jurisdiction of Incorporation LCP Edge Intermediate, LLC Delaware Edge Systems Holdings Corporation Delaware Edge Systems Intermediate, LLC Delaware Edge Systems, LLC California The HydraFacial Company MX, S. de R.L. de C.V. Mexico The HydraFacial Company Mexico Holdings, LLC Delaware The HydraFacial Company Singapo |
|
| March 1, 2022 |
EXHIBIT 10.8 August 3, 2021 Indra Pamamull [REDACTED] Dear Indra, We are excited to extend you an offer to join Edge Systems d/b/a HydraFacial, a BeautyHealth Company, as our President of APAC. In this role, you will report directly to Clint Carnell, Chief Executive Officer. You will be employed in Singapore, although your role will require you to travel throughout the APAC region as well as to ot |
|
| March 1, 2022 |
STRICTLY PRIVATE AND CONFIDENTIAL August 4, 2021 Indra Pamamull [REDACTED] Dear Indra Pamamull, EMPLOYMENT ? APPOINTMENT AS President of APAC OF CLIENT, Edge Systems LLC dba The HydraFacial Company We, GoGlobal GEO Pte. |
|
| February 22, 2022 |
Exhibit 99.1 The Beauty Health Company Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results Provides Fiscal Year 2022 Outlook Long Beach, Calif., February 22, 2022 ? The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacialTM, today announced financial results for the f |
|
| February 22, 2022 |
▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ▪ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? |
|
| February 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| February 14, 2022 |
SKIN / The Beauty Health Company Class A / Luxor Capital Group, LP Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 1)* The Beauty Health Company (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 88331L108 (CUSIP Number) December 31, |
|
| February 11, 2022 |
SKIN / The Beauty Health Company Class A / BAUPOST GROUP LLC/MA - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* The Beauty Health Company (Name of Issuer) Common Stock (Title of Class of Securities) 88331L108 (CUSIP Number) Calendar Year 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| February 9, 2022 |
SKIN / The Beauty Health Company Class A / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Beauty Health Co. Title of Class of Securities: Common Stock CUSIP Number: 88331L108 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule 13d-1(b) ??Rule |
|
| January 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 20, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commiss |
|
| January 20, 2022 |
Exhibit 99.1 The Beauty Health Company Announces Appointment of Andrew Stanleick as President and Chief Executive Officer Highly Accomplished Brand Builder with 25+ Years of Global Beauty & Retail Experience and Proven Record of Scaling Businesses Internationally Joins the BeautyHealth Team and Board of Directors Long Beach, Calif., ? January 20, 2022 ? The Beauty Health Company (?BeautyHealth? or |
|
| January 20, 2022 |
424B3 1 a8k-ceoappointment1.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 PROSPECTUS SUPPLEMENT NO. 11 (to prospectus dated July 26, 2021) THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to |
|
| January 20, 2022 |
Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (?Agreement?) is entered into as of January 20, 2022 and effective as of February 7, 2022 (the ?Effective Date?) between The Beauty Health Company (?Parent?), Edge Systems LLC d/b/a The HydraFacial Company (the ?OpCo? and, together with Parent, the ?Company?), and Andrew Stanleick (?Executive?). WHEREAS, effective as of the Effective Date |
|
| January 10, 2022 |
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Direct Distributor ? ? ? ? ? ? ? ? ? ? o o o o o 1 2 3 4 5 6 7 For the Nine Months Ended September 30, 2021 ($000s) Net Sales $182,197 Less: Cost of Sales (57,131) Gross Profit (GAAP) $125,066 Gross Margin (GAAP) 69% Adjusted to exclude the following: Stock-Based Compensation Expense 222 Depreciation and Amortization Expense 7,747 Adjusted Gross Prof |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commiss |
|
| January 10, 2022 |
Exhibit 99.1 The Beauty Health Company Confirms Fiscal 2021 Outlook Ahead of the 2022 ICR Conference Expects Fiscal Year 2021 Net Sales Around the High End of Guidance Range and Reiterates Adjusted EBITDA Long Beach, Calif., January 10, 2022 ? The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with HydraFacialTM, |
|
| January 4, 2022 |
EXHIBIT 10.1 EXECUTION VERSION CREDIT AGREEMENT dated as of December 30, 2021 among EDGE SYSTEMS LLC, as Borrower The Other Loan Parties Party Hereto The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent, JPMORGAN CHASE BANK, N.A., as Sole Bookrunner and Sole Lead Arranger TABLE OF CONTENTS Page ARTICLE I Definitions 1 SECTION 1.01. Defined Terms 1 SECTION 1.02. Classific |
|
| January 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| January 4, 2022 |
PROSPECTUS SUPPLEMENT NO. 10 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| November 12, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39565 |
|
| November 12, 2021 |
PROSPECTUS SUPPLEMENT NO. 9 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| November 9, 2021 |
PROSPECTUS SUPPLEMENT NO. 8 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commiss |
|
| November 9, 2021 |
The Beauty Health Company Announces CEO Transition Exhibit 99.2 The Beauty Health Company Announces CEO Transition LONG BEACH, Calif. ? (BUSINESS WIRE)?November 9, 2021 - The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacialTM, today announced that, following its third quarter record performance, Clint Carnell will be transitioning |
|
| November 9, 2021 |
Exhibit 99.1 The Beauty Health Company Reports Record Third Quarter 2021 Financial Results Raises Full Year 2021 Guidance Long Beach, Calif., November 9, 2021 ? The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacialTM, today announced financial results for the third quarter ended Se |
|
| November 8, 2021 |
EX-99 2 ex991-pressreleasewarrantr.htm EX-99.1 Exhibit 99.1 The Beauty Health Company Announces the Results of the Completed Redemption of All Outstanding Public Warrants Long Beach, Calif., November 8, 2021 – The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced t |
|
| November 8, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commiss |
|
| November 8, 2021 |
424B3 1 a424b3-1108warrantredempti.htm 424B3 PROSPECTUS SUPPLEMENT NO. 7 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being fi |
|
| October 19, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commiss |
|
| October 19, 2021 |
PROSPECTUS SUPPLEMENT NO. 6 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| October 19, 2021 |
Exhibit 99.1 The Beauty Health Company Reminds Investors of Redemption of Public Warrants Approximately 8.47 million public warrants remain unexercised as of October 18, 2021 Long Beach, Calif., October 19, 2021 ? The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announc |
|
| October 4, 2021 |
The Beauty Health Company Announces Redemption of All Outstanding Warrants Exhibit 99.1 The Beauty Health Company Announces Redemption of All Outstanding Warrants Long Beach, Calif., October 4, 2021 ? The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced that the Company will redeem all of its outstanding warrants (the ?Public Warrants?) |
|
| October 4, 2021 |
PROSPECTUS SUPPLEMENT NO. 5 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| October 4, 2021 |
NOTICE OF REDEMPTION OF CERTAIN WARRANTS (CUSIP 92538T112) EXHIBIT 99.2 October 4, 2021 NOTICE OF REDEMPTION OF CERTAIN WARRANTS (CUSIP 92538T112) Dear Warrant Holder, The Beauty Health Company (the ?Company?) hereby gives notice that it is redeeming, at 5:00 p.m. New York City time on November 3, 2021 (the ?Redemption Date?), all of the Company?s outstanding warrants (the ?Public Warrants?) to purchase shares of the Company?s Class A common stock, par va |
|
| October 4, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissi |
|
| September 14, 2021 |
PROSPECTUS SUPPLEMENT NO. 4 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| September 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| September 14, 2021 |
Form of Confirmation for Capped Call Transactions Exhibit 10.1 Form of Confirmation for Capped Call Transactions []1 To: The Beauty Health Company 2165 Spring Street Long Beach, CA 90806 Attention: [] Telephone No.: [] From: [] Re: [Base][Additional] Capped Call Transaction 2,3 Ref. No: [] 4 Date: [], 2021 Dear Ladies and Gentlemen: The purpose of this communication (this ?Confirmation?) is to set forth the terms and conditions of the above-refer |
|
| September 14, 2021 |
Exhibit 4.1 EXECUTION VERSION THE BEAUTY HEALTH COMPANY and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of September 14, 2021 1.25% Convertible Senior Notes due 2026 TABLE OF CONTENTS Page Article 1. Definitions; Rules of Construction 1 Section 1.01. Definitions. 1 Section 1.02. Other Definitions. 12 Section 1.03. Rules of Construction. 13 Article 2. The Notes 14 Section 2.01. For |
|
| September 10, 2021 |
The Beauty Health Company Prices Upsized $650 Million Convertible Senior Notes Offering Exhibit 99.1 The Beauty Health Company Prices Upsized $650 Million Convertible Senior Notes Offering LONG BEACH, Calif.?(BUSINESS WIRE)?September 9, 2021?The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN) today announced the pricing of its offering of $650,000,000 aggregate principal amount of 1.25% convertible senior notes due 2026 (the ?notes?) in a private offering to pers |
|
| September 10, 2021 |
PROSPECTUS SUPPLEMENT NO. 3 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| September 10, 2021 |
As filed with the Securities and Exchange Commission on September 10, 2021 As filed with the Securities and Exchange Commission on September 10, 2021 Registration No. |
|
| September 10, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| September 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commis |
|
| September 8, 2021 |
PROSPECTUS SUPPLEMENT NO. 2 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| September 8, 2021 |
The Beauty Health Company Announces Proposed Convertible Senior Notes Offering Exhibit 99.1 The Beauty Health Company Announces Proposed Convertible Senior Notes Offering LONG BEACH, Calif.?(BUSINESS WIRE)?Sep. 8, 2021?The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amount of convertible senior notes due 2026 (the ?notes?) in a private off |
|
| August 13, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39565 The Beauty Heal |
|
| August 13, 2021 |
PROSPECTUS SUPPLEMENT NO. 1 (to prospectus dated July 26, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-257995 THE BEAUTY HEALTH COMPANY 89,501,743 SHARES OF CLASS A COMMON STOCK 9,333,333 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 24,666,666 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement is being filed to update and supplement the information |
|
| August 10, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2021 THE BEAUTY HEALTH COMPANY (Exact name of registrant as specified in its charter) Delaware 001-39565 85-1908962 (State or other jurisdiction of incorporation) (Commissi |
|
| August 10, 2021 |
Exhibit 99.1 The Beauty Health Company Reports Record Second Quarter 2021 Financial Results Raises Full Year 2021 Sales Guidance Long Beach, Calif., August 10, 2021 ? The Beauty Health Company ("BeautyHealth" or the "Company"; NASDAQ:SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacial, today announced financial results for the second quarter end |
